GlassScriptPhysician profile
Stephen G Keim
NPI 1821080029
$17,480.09
in general payments reported to CMS, 2019-2025
24 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,730 · 2020: $4,886 · 2021: $4,327 · 2023: $13.07 · 2024: $416 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361 · Travel and Lodging: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.49 |
| Travel and Lodging | $175.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $11,417.42 | 2019-2020 | |
| Medtronic, INC. | $3,618.00 | 2021-2025 | Pulseselect |
| Abbott Laboratories | $643.06 | 2019-2020 | |
| Boston Scientific Corporation | $300.91 | 2019-2021 | |
| Biosense Webster, INC. | $249.59 | 2020-2025 | Carto 3, Qdot Micro Catheter |
| Medical Device Business Services, INC. | $246.00 | 2024 | Carto 3 |
| Atricure, INC. | $207.47 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $171.30 | 2019-2021 | |
| Merit Medical Systems INC | $113.93 | 2024 | Worley Adv Coronary Sinus Guide |
| Janssen Pharmaceuticals, INC | $105.26 | 2019-2021 | |
| Irhythm Technologies, INC. | $84.55 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $65.79 | 2019-2021 | |
| Amarin Pharma, INC. | $49.72 | 2019-2021 | |
| Amgen INC. | $41.60 | 2019-2020 | |
| Pfizer INC. | $31.71 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $24.34 | 2021 | |
| Cordis US Corp. | $19.55 | 2025 | Mynx Control Venous |
| Lundbeck LLC | $16.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.01 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.90 | 2021 | |
| Cardiva Medical, INC. | $14.37 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cook Medical LLC | $13.07 | 2023 | Evolution |
| Amryt Pharma Holdings LTD | $11.48 | 2021 | |
| Cvrx, INC. | $4.39 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Keim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.